BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 31763794)

  • 1. CRISPR-Cas9-Guided Genome Engineering in Caenorhabditis elegans.
    Kim HM; Colaiácovo MP
    Curr Protoc Mol Biol; 2019 Dec; 129(1):e106. PubMed ID: 31763794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas9-Guided Genome Engineering in C. elegans.
    Kim HM; Colaiácovo MP
    Curr Protoc Mol Biol; 2016 Jul; 115():31.7.1-31.7.18. PubMed ID: 27366893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creating Genome Modifications in C. elegans Using the CRISPR/Cas9 System.
    Calarco JA; Friedland AE
    Methods Mol Biol; 2015; 1327():59-74. PubMed ID: 26423968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision genome editing using CRISPR-Cas9 and linear repair templates in C. elegans.
    Paix A; Folkmann A; Seydoux G
    Methods; 2017 May; 121-122():86-93. PubMed ID: 28392263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Microinjection to Generate Genetically Modified Caenorhabditis elegans by CRISPR/Cas9 Editing.
    Iyer J; DeVaul N; Hansen T; Nebenfuehr B
    Methods Mol Biol; 2019; 1874():431-457. PubMed ID: 30353529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient genome editing in Caenorhabditis elegans by CRISPR-targeted homologous recombination.
    Chen C; Fenk LA; de Bono M
    Nucleic Acids Res; 2013 Nov; 41(20):e193. PubMed ID: 24013562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple CRISPR-Cas9 Genome Editing in Saccharomyces cerevisiae.
    Laughery MF; Wyrick JJ
    Curr Protoc Mol Biol; 2019 Dec; 129(1):e110. PubMed ID: 31763795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgene-free genome editing by germline injection of CRISPR/Cas RNA.
    Schwartz HT; Sternberg PW
    Methods Enzymol; 2014; 546():441-57. PubMed ID: 25398352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9-Based Multiplex Genome Editing in Monocot and Dicot Plants.
    Ma X; Liu YG
    Curr Protoc Mol Biol; 2016 Jul; 115():31.6.1-31.6.21. PubMed ID: 27366892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Efficiency, Homology-Directed Genome Editing in Caenorhabditis elegans Using CRISPR-Cas9 Ribonucleoprotein Complexes.
    Paix A; Folkmann A; Rasoloson D; Seydoux G
    Genetics; 2015 Sep; 201(1):47-54. PubMed ID: 26187122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering the Caenorhabditis elegans genome with CRISPR/Cas9.
    Waaijers S; Boxem M
    Methods; 2014 Aug; 68(3):381-8. PubMed ID: 24685391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peel-1 negative selection promotes screening-free CRISPR-Cas9 genome editing in Caenorhabditis elegans.
    McDiarmid TA; Au V; Moerman DG; Rankin CH
    PLoS One; 2020; 15(9):e0238950. PubMed ID: 32960926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SapTrap, a Toolkit for High-Throughput CRISPR/Cas9 Gene Modification in Caenorhabditis elegans.
    Schwartz ML; Jorgensen EM
    Genetics; 2016 Apr; 202(4):1277-88. PubMed ID: 26837755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
    Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
    Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliable CRISPR/Cas9 Genome Engineering in
    El Mouridi S; Lecroisey C; Tardy P; Mercier M; Leclercq-Blondel A; Zariohi N; Boulin T
    G3 (Bethesda); 2017 May; 7(5):1429-1437. PubMed ID: 28280211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heritable custom genomic modifications in Caenorhabditis elegans via a CRISPR-Cas9 system.
    Tzur YB; Friedland AE; Nadarajan S; Church GM; Calarco JA; Colaiácovo MP
    Genetics; 2013 Nov; 195(3):1181-5. PubMed ID: 23979579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
    Najah S; Saulnier C; Pernodet JL; Bury-Moné S
    BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential pitfalls of CRISPR/Cas9-mediated genome editing.
    Peng R; Lin G; Li J
    FEBS J; 2016 Apr; 283(7):1218-31. PubMed ID: 26535798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Genome Editing and its Potential Enhancement through CRISPR Guide RNA and Cas9 Modifications.
    Batzir NA; Tovin A; Hendel A
    Pediatr Endocrinol Rev; 2017 Jun; 14(4):353-363. PubMed ID: 28613045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.